Streamline Ev To Free Cash Flow vs Cash Conversion Cycle Analysis

STRM Stock

USD 2.31 0.02 0.87%

Streamline Health financial indicator trend analysis is much more than just breaking down Streamline Health prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Streamline Health is a good investment. Please check the relationship between Streamline Health Ev To Free Cash Flow and its Cash Conversion Cycle accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Ev To Free Cash Flow vs Cash Conversion Cycle

Ev To Free Cash Flow vs Cash Conversion Cycle Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Streamline Health Ev To Free Cash Flow account and Cash Conversion Cycle. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Streamline Health's Ev To Free Cash Flow and Cash Conversion Cycle is -0.05. Overlapping area represents the amount of variation of Ev To Free Cash Flow that can explain the historical movement of Cash Conversion Cycle in the same time period over historical financial statements of Streamline Health Solutions, assuming nothing else is changed. The correlation between historical values of Streamline Health's Ev To Free Cash Flow and Cash Conversion Cycle is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Free Cash Flow of Streamline Health Solutions are associated (or correlated) with its Cash Conversion Cycle. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash Conversion Cycle has no effect on the direction of Ev To Free Cash Flow i.e., Streamline Health's Ev To Free Cash Flow and Cash Conversion Cycle go up and down completely randomly.

Correlation Coefficient

-0.05

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Cash Conversion Cycle

Most indicators from Streamline Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Streamline Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

As of the 15th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.47, while Selling General Administrative is likely to drop about 8.3 M.

	2021	2022	2023	2024 (projected)
Total Revenue	17.4M	24.9M	22.6M	19.1M
Depreciation And Amortization	3.6M	4.9M	4.9M	2.9M

Total Revenue Depreciation And Amortization

Streamline Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Cash	Cash And Short Term Investments	Property Plant And Equipment Gross	Other Liab	Other Assets	Long Term Debt	Common Stock Total Equity
Total Assets		0.83	0.58	0.86	0.95	0.31	-0.2	-0.31	0.29	0.96	0.39	0.75	0.44	0.81	-0.38	0.45	0.91	0.85	-0.07	0.8	0.8	-0.03	0.62	0.06	0.6	0.23
Short Long Term Debt Total	0.83		0.55	0.75	0.65	0.4	0.22	-0.16	0.43	0.8	0.33	0.78	0.09	0.86	-0.37	0.27	0.9	0.71	-0.09	0.58	0.58	0.14	0.52	0.29	0.87	0.18
Other Current Liab	0.58	0.55		0.54	0.6	-0.42	0.22	-0.39	-0.13	0.64	0.52	0.54	0.56	0.35	0.02	0.51	0.47	0.33	-0.09	0.26	0.26	-0.51	-0.07	0.48	0.54	0.62
Total Current Liabilities	0.86	0.75	0.54		0.76	0.21	0.01	-0.38	0.34	0.86	0.38	0.71	0.32	0.64	-0.35	0.45	0.87	0.66	0.25	0.53	0.53	-0.17	0.35	0.04	0.43	0.19
Total Stockholder Equity	0.95	0.65	0.6	0.76		0.17	-0.33	-0.41	0.11	0.93	0.47	0.62	0.62	0.64	-0.24	0.55	0.76	0.78	-0.07	0.78	0.78	-0.15	0.52	0.06	0.42	0.34
Property Plant And Equipment Net	0.31	0.4	-0.42	0.21	0.17		-0.07	0.3	0.46	0.26	-0.22	0.19	-0.1	0.47	-0.46	-0.29	0.4	0.34	-0.11	0.29	0.29	0.84	0.66	-0.18	0.29	-0.53
Net Debt	-0.2	0.22	0.22	0.01	-0.33	-0.07		-0.3	0.02	-0.07	0.35	0.01	-0.25	-0.03	0.27	0.23	-0.02	-0.39	0.02	-0.57	-0.57	-0.07	-0.51	0.56	0.23	0.38
Retained Earnings	-0.31	-0.16	-0.39	-0.38	-0.41	0.3	-0.3		0.26	-0.45	-0.88	0.04	-0.29	-0.01	-0.35	-0.97	-0.18	0.01	-0.13	0.0	0.0	0.58	0.34	-0.28	0.14	-0.85
Accounts Payable	0.29	0.43	-0.13	0.34	0.11	0.46	0.02	0.26		0.17	-0.21	0.48	-0.42	0.5	-0.59	-0.23	0.48	0.44	0.19	0.33	0.33	0.47	0.53	-0.01	0.41	-0.27
Non Current Assets Total	0.96	0.8	0.64	0.86	0.93	0.26	-0.07	-0.45	0.17		0.51	0.61	0.57	0.73	-0.31	0.55	0.86	0.67	-0.07	0.62	0.62	-0.1	0.48	0.18	0.55	0.34
Non Currrent Assets Other	0.39	0.33	0.52	0.38	0.47	-0.22	0.35	-0.88	-0.21	0.51		0.12	0.34	0.09	0.24	0.89	0.23	0.07	0.01	0.05	0.05	-0.38	-0.33	0.64	0.15	0.85
Net Receivables	0.75	0.78	0.54	0.71	0.62	0.19	0.01	0.04	0.48	0.61	0.12		0.1	0.71	-0.35	0.1	0.78	0.82	0.0	0.62	0.62	0.01	0.43	0.15	0.68	0.01
Common Stock Shares Outstanding	0.44	0.09	0.56	0.32	0.62	-0.1	-0.25	-0.29	-0.42	0.57	0.34	0.1		0.06	0.13	0.37	0.19	0.12	-0.11	0.16	0.16	-0.27	0.02	0.17	-0.01	0.25
Non Current Liabilities Total	0.81	0.86	0.35	0.64	0.64	0.47	-0.03	-0.01	0.5	0.73	0.09	0.71	0.06		-0.53	0.11	0.94	0.78	-0.35	0.69	0.69	0.21	0.74	0.05	0.77	-0.03
Other Current Assets	-0.38	-0.37	0.02	-0.35	-0.24	-0.46	0.27	-0.35	-0.59	-0.31	0.24	-0.35	0.13	-0.53		0.34	-0.51	-0.42	0.32	-0.43	-0.43	-0.55	-0.67	0.07	-0.5	0.37
Other Stockholder Equity	0.45	0.27	0.51	0.45	0.55	-0.29	0.23	-0.97	-0.23	0.55	0.89	0.1	0.37	0.11	0.34		0.27	0.16	0.12	0.16	0.16	-0.58	-0.24	0.29	-0.03	0.88
Total Liab	0.91	0.9	0.47	0.87	0.76	0.4	-0.02	-0.18	0.48	0.86	0.23	0.78	0.19	0.94	-0.51	0.27		0.8	-0.11	0.69	0.69	0.06	0.64	0.05	0.69	0.06
Total Current Assets	0.85	0.71	0.33	0.66	0.78	0.34	-0.39	0.01	0.44	0.67	0.07	0.82	0.12	0.78	-0.42	0.16	0.8		-0.06	0.95	0.95	0.1	0.74	-0.17	0.56	-0.02
Short Term Debt	-0.07	-0.09	-0.09	0.25	-0.07	-0.11	0.02	-0.13	0.19	-0.07	0.01	0.0	-0.11	-0.35	0.32	0.12	-0.11	-0.06		-0.11	-0.11	-0.24	-0.25	-0.23	-0.38	0.0
Cash	0.8	0.58	0.26	0.53	0.78	0.29	-0.57	0.0	0.33	0.62	0.05	0.62	0.16	0.69	-0.43	0.16	0.69	0.95	-0.11		1.0	0.09	0.78	-0.26	0.47	0.01
Cash And Short Term Investments	0.8	0.58	0.26	0.53	0.78	0.29	-0.57	0.0	0.33	0.62	0.05	0.62	0.16	0.69	-0.43	0.16	0.69	0.95	-0.11	1.0		0.09	0.78	-0.26	0.47	0.01
Property Plant And Equipment Gross	-0.03	0.14	-0.51	-0.17	-0.15	0.84	-0.07	0.58	0.47	-0.1	-0.38	0.01	-0.27	0.21	-0.55	-0.58	0.06	0.1	-0.24	0.09	0.09		0.52	-0.01	0.29	-0.59
Other Liab	0.62	0.52	-0.07	0.35	0.52	0.66	-0.51	0.34	0.53	0.48	-0.33	0.43	0.02	0.74	-0.67	-0.24	0.64	0.74	-0.25	0.78	0.78	0.52		-0.39	0.49	-0.4
Other Assets	0.06	0.29	0.48	0.04	0.06	-0.18	0.56	-0.28	-0.01	0.18	0.64	0.15	0.17	0.05	0.07	0.29	0.05	-0.17	-0.23	-0.26	-0.26	-0.01	-0.39		0.44	0.49
Long Term Debt	0.6	0.87	0.54	0.43	0.42	0.29	0.23	0.14	0.41	0.55	0.15	0.68	-0.01	0.77	-0.5	-0.03	0.69	0.56	-0.38	0.47	0.47	0.29	0.49	0.44		0.09
Common Stock Total Equity	0.23	0.18	0.62	0.19	0.34	-0.53	0.38	-0.85	-0.27	0.34	0.85	0.01	0.25	-0.03	0.37	0.88	0.06	-0.02	0.0	0.01	0.01	-0.59	-0.4	0.49	0.09

Click cells to compare fundamentals

Streamline Health Account Relationship Matchups

Streamline Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	31.7M	26.0M	61.8M	61.5M	41.7M	32.0M
Short Long Term Debt Total	3.8M	2.7M	10.1M	9.7M	10.6M	6.0M
Other Current Liab	2.5M	1.5M	6.0M	6.7M	3.6M	2.8M
Total Current Liabilities	15.6M	7.4M	13.5M	16.8M	13.7M	10.2M
Total Stockholder Equity	16.0M	17.5M	34.0M	35.5M	18.8M	15.7M
Property Plant And Equipment Net	152K	495K	341K	111K	88K	83.6K
Net Debt	2.2M	312K	256K	3.2M	7.4M	7.7M
Retained Earnings	(79.4M)	(79.1M)	(85.7M)	(97.0M)	(115.7M)	(109.9M)
Accounts Payable	1.3M	272K	778K	626K	1.3M	1.1M
Non Current Assets Total	25.1M	18.7M	46.7M	45.5M	32.9M	19.4M
Non Currrent Assets Other	695K	886K	948K	1.7M	1.7M	1.2M
Net Receivables	4.0M	3.1M	4.7M	8.7M	5.0M	5.1M
Common Stock Shares Outstanding	22.7M	30.2M	42.8M	49.3M	3.8M	3.6M
Liabilities And Stockholders Equity	31.7M	26.0M	61.8M	61.5M	41.7M	32.0M
Non Current Liabilities Total	55K	1.1M	14.3M	9.2M	9.2M	6.8M
Other Current Assets	919K	1.8M	568K	710K	629K	1.2M
Other Stockholder Equity	95.1M	96.3M	119.2M	132.0M	133.9M	140.6M
Total Liab	15.6M	8.5M	27.8M	26.0M	22.9M	16.6M
Total Current Assets	6.6M	7.3M	15.1M	16.0M	8.8M	12.7M
Short Term Debt	3.8M	1.7M	454K	785K	1.5M	1.2M
Cash	1.6M	2.4M	9.9M	6.6M	3.2M	5.6M
Cash And Short Term Investments	1.6M	2.4M	9.9M	6.6M	3.2M	5.6M
Property Plant And Equipment Gross	152K	495K	341K	357K	379K	360.1K
Other Liab	55K	130K	4.6M	271K	311.7K	296.1K
Other Assets	695K	886K	948K	1.7M	1.5M	1.0M
Common Stock Total Equity	208K	305K	316K	576K	662.4K	695.5K
Common Stock	305K	316K	478K	576K	590K	619.5K
Property Plant Equipment	152K	104K	341K	5.9M	6.8M	7.2M
Current Deferred Revenue	8.0M	3.9M	5.8M	8.4M	7.1M	6.8M
Intangible Assets	8.7M	6.6M	22.3M	20.6M	17.9M	13.0M
Inventory	1.3M	901K	1.4M	1.0	0.9	0.86
Net Tangible Assets	(8.2M)	208K	(11.4M)	(2.4M)	(2.7M)	(2.9M)
Retained Earnings Total Equity	(76.6M)	(79.4M)	(79.1M)	(97.0M)	(87.3M)	(91.7M)
Long Term Debt Total	3.9M	3.4M	989K	9.0M	8.1M	5.4M
Capital Surpluse	82.5M	95.1M	96.3M	132.0M	151.8M	89.1M
Deferred Long Term Liab	55K	130K	806K	167K	150.3K	142.8K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:

How To Invest In Streamline

Details

Is Streamline Stock a good investment?

Details

What is Streamline Health's Net Worth?

Details

Largest Health Care Technology Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

12.131

Earnings Share

(4.62)

Revenue Per Share

5.249

Quarterly Revenue Growth

(0.01)

Return On Assets

(0.11)

The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Streamline Ev To Free Cash Flow vs Cash Conversion Cycle Analysis

Ev To Free Cash Flow vs Cash Conversion Cycle

Ev To Free Cash Flow vs Cash Conversion Cycle Correlation Analysis

Correlation Coefficient

Ev To Free Cash Flow

Cash Conversion Cycle

Streamline Health fundamental ratios Correlations

Streamline Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Streamline Health fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 0.96	Total Assets
Total Stockholder Equity	+ 0.95	Total Assets
Cash	+ 0.95	Total Current Assets
Cash And Short Term Investments	+ 0.95	Total Current Assets
Total Liab	+ 0.94	Non Current Liabilities Total

Other Stockholder Equity	- 0.97	Retained Earnings
Non Currrent Assets Other	- 0.88	Retained Earnings
Common Stock Total Equity	- 0.85	Retained Earnings
Other Liab	- 0.67	Other Current Assets
Common Stock Total Equity	- 0.59	Property Plant And Equipment Gross
Other Current Assets	- 0.59	Accounts Payable